We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IQV:NYSEIQVIA Holdings, Inc. Analysis

Data as of 2026-05-24 - not real-time

$167.90

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

IQVIA delivered an earnings surprise by beating consensus estimates, underscoring resilient profitability and a solid top‑line momentum that outpaced prior periods. Revenue growth remains healthy and margins are comfortably above industry averages, while the forward earnings outlook suggests continued upside. The stock trades below the discounted cash‑flow fair value estimate, offering a margin of safety relative to its current price.
Technical gauges, however, point to short‑term weakness: the price sits under the short‑term moving averages, the MACD has turned bearish and volume is on a downtrend, contributing to elevated volatility. Nonetheless, the recent $2 billion share repurchase authorization and a strong analyst consensus of “strong buy” provide a supportive backdrop for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMA, negative MACD histogram)
  • High recent volatility and decreasing volume
  • Earnings beat provides short‑term price support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Stock priced below DCF fair value
  • Strong revenue growth and expanding margins
  • Board‑approved $2 billion buyback enhances shareholder returns

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable earnings growth driven by diversified healthcare services
  • Strategic global footprint mitigates single‑region exposure
  • Analyst consensus remains heavily weighted toward a strong buy rating

Key Metrics & Analysis

Financial Health

Revenue Growth8.40%
Profit Margin8.33%
P/E Ratio20.9
ROE22.49%
ROA5.13%
Debt/Equity255.43
P/B Ratio4.4
Op. Cash Flow$2.7B
Free Cash Flow$2.2B
Industry P/E27.6

Technical Analysis

TrendBearish
RSI46.2
Support$154.50
Resistance$182.70
MA 20$169.05
MA 50$169.35
MA 200$196.09
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$155.56
Target Price$228.60
Upside/Downside36.15%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.24
Volatility45.26%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.